MedTrace Logo

Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).

NCT03163186 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2017-05-22

No results posted yet for this study

Summary

To evaluate the safety, advantages, and appropriateness of performing transarterial hepatic emobolization of liver cancer via arterial access from the radial artery versus conventional transfemoral arterial access. The procedures that will be followed utilizing arterial access include transarterial chemoembolization (TACE), specifically performed for hepatocellular carcinoma, and transarterial embolization (TAE) which is performed for types of liver tumors such as carcinoid tumors or liver metastases.

Conditions

  • Hepatic Carcinoma
  • Chemoembolizaton
  • Transarterial Embolization

Interventions

PROCEDURE

Transarterial embolization

Transarterial hepatic embolization of liver cancer

Sponsors & Collaborators

  • Medical University of South Carolina

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-01
Primary Completion
2016-04-20
Completion
2016-08-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03163186 on ClinicalTrials.gov